Open access peer-reviewed chapter

Application of Herbal Medicine as Proliferation and Differentiation Effectors of Human Stem Cells

Written By

Preethi Vidya Udagama and Vindya Udalamaththa

Submitted: 21 May 2017 Reviewed: 24 November 2017 Published: 05 November 2018

DOI: 10.5772/intechopen.72711

From the Edited Volume

Herbal Medicine

Edited by Philip F. Builders

Chapter metrics overview

1,862 Chapter Downloads

View Full Metrics


One of the main streams of traditional medicine is herbal medicine; a wide range of medicinal plants and their individual parts are used for therapy. Though not scientifically validated, this traditional medicine practice is much popular in countries such as India, China and Sri Lanka and in many other countries in South, Southeast and Eastern Asia due mainly to its healing capabilities. More recently, scientists initiated the chemical analyses of these medicinal plants, obtaining invaluable results. The latest addition to such investigations is studies on effects of herbal extracts on different types of stem cells. An extensive summary of such reported studies is presented in this chapter, mainly categorizing these into proliferation stimulatory effects on stem cells and inhibitory effects on cancer stem cells (CSCs), where both properties are beneficial in cell therapy procedures. At present, standardizing the products and limited knowledge on the mechanisms of action and pathways of these have critically limited the use of herbal extracts in therapeutics. However, we believe that in the near future scientists would be focusing on herbal remedies to replace the use of synthetic stimulants and cancer drugs to overcome the disadvantages of these, such as toxicity, side effects and exorbitant costs.


  • herbal extracts
  • stem cell therapy
  • cellular stimulants
  • proliferation and differentiation
  • cancer stem cells

1. Introduction

Traditional medicine is a popular treatment method for a wide range of diseases in many countries due to its claims of therapeutic activity by patients. The knowledge handed over from generation to generation since ancient ages is the foundation of traditional medicine; hence, the methods of treatment vary depending on the country and the region of origin. In addition, a single region may use different types of traditional medicine due to different ethnic backgrounds of its citizens migrated from different regions of the world.

As the World Health Organization (WHO) defines ‘Traditional medicine is the sum total of the knowledge, skills, and practices based on the theories, beliefs, and experiences indigenous to different cultures, whether explicable or not, used in the maintenance of health as well as in the prevention, diagnosis, improvement or treatment of physical and mental illness [1]’.

Herbal medicine is one of the main streams of every traditional medicine practice regardless of the different types such as Indian traditional medicine (ITM), Sri Lankan traditional medicine (SLTM), traditional Chinese medicine (TCM), Arabic traditional medicine (ATM), African traditional medicine and South American traditional medicine. According to the WHO, medicinal ingredients of herbal medicine include herbs, herbal materials, herbal preparations and finished herbal products that contain active ingredients as parts of plants or other plant materials or combinations; also, 75% of the world’s population use herbs for their basic healthcare needs [2]. Archaeological proof of history in the use of herbal medicine dates back to more than 5000 years [3], along with evidence from ancient literature such as Arkaprakasa (pharmacology and pharmacy) and Kumaratantra (paediatric diseases and management) claimed to be written by the great king Ravana of Sri Lanka where different herbal preparations were introduced for treatment and management of different types of diseases [4]. An in-depth account of the historical events on the use of herbals is reviewed by Petrovska [5]. The same disease could be treated in different countries, with different types of plant-based remedies mainly depending on their indigenous plant varieties and traditional knowledge handed down to generations through thousands of years [6, 7].

Even though history strongly supports the use of herbal medicine, over the last century, traditional knowledge and its effective uses were challenged by Western medical practitioners due to lack of scientific validation of these claims and evidence [2]. However in the recent decades, perspectives on herbal medicine had been evolving into positive thoughts with the isolation of many different effective drugs from plant materials. Existing synthetic drugs are highly expensive, and most of these are required to be replaced due to their instability in vivo [8]. Continuous synthetic drug doses may cause side effects and toxicity [9]; hence, these disadvantages accelerated the search for alternatives derived from natural products. With the technological advances in health and basic sciences, multi screening drug facilities to investigate specific therapeutic activities was made possible. Isolated chemicals and bioactive compounds from plant materials are the main source of modern pharmaceutical drugs, which are either naturally derived or synthetic analogues of existing natural compounds [10]. Among the many different approved drugs derived from herbal material, anticancer drugs [11], antidiabetic drugs [12] and skin care products [13] have maintained topmost status in this long list. In cancer therapy, 25% of the drugs used in the last 20 years are directly derived from plant material [11], and 49% of the antidiabetic drugs approved in the last 10 years were plant derived [12]. Both in developing and developed countries, obesity is becoming a socio-economic burden rendering global populations unhealthy, leading to many non-communicable diseases [14]. There are many weight-reducing supplements prepared by herbal extracts selling in an increased rate in the local markets, even without clinical approval, due to the popularity of the products among the users. Hence, researches are in the timely search of antiobesity herbal preparations [14] as these would flourish as multimillion dollar businesses in the global market.

In order to investigate the different activities of plant-derived extracts, the use of experimental platforms is important prior to clinical trials. Human stem cells are one such experimental platform to investigate therapeutic activities of herbal extracts in vitro. Stem cells with the ability to self-renew and differentiate into many cell lineages have been accepted and extensively used by scientists globally as a reliable tool in their research. Of the many different sources of stem cells, bone marrow stem cells have been used widely in research due to their well-explained characteristics, but the usage paradigm is shifting towards umbilical cord- and cord blood-derived stem cells due to the advantages such as minimum ethical issues, high availability and easy isolation methods of the latter [15]. Since stem cells possess multi-lineage differentiation ability, stimulated differentiation of stem cells could be used to investigate on therapeutics applicable to different types of diseases. For example, human mesenchymal stem cells (hMSCs) could be differentiated into osteocytes, adipocytes and chondrocytes; hence, herbal extracts could be used to investigate the suppression or the stimulation of adipogenic, osteogenic and chondrogenic differentiation properties of stem cells and therefore used to investigate the therapeutic possibilities of diseases related to the above cell lineages in vitro. Human haematopoietic stem cells are the progenitors of cells of blood tissue; hence, those can be differentiated into different blood cell types, and herbal extracts could be used in the above manner to search for therapeutic agents for blood cell-related disorders. Induced pluripotent stem cells (iPSCs), a group of adult somatic cells which are genetically engineered to function as embryonic-like stem cells, are also widely used as disease model stem cell lines in investigations of therapeutic candidates for different disease targets [16]. iPSC-derived cardiomyocytes from patients with cardiovascular diseases and iPSC-derived neurons from patients with neurodegenerative disorders are currently used in high-throughput drug screening [17]. Undifferentiated stem cells are transplanted in order to regenerate tissue in vivo; hence, stimulation factors are important to increase the regeneration speed. The issues of synthetic growth factors and stimulants, i.e. possible side effects, high costs and low availability, remain unchanged; therefore, natural stimulants are preferred. Hence, research is ongoing in search of natural stimulants for stem cells [8]. Furthermore, growth factors, cytokines and vesicles secreted by hMSCs are known as the secretome of hMSCs, and these bioactive factors isolated singly or as a mixture are investigated as potential therapeutic agents, which could reduce the complexities of therapy using cell transplantations [18].

Although it is reported that over 53,000 plant species are used in herbal medicine globally [2], only a few are being tested and reported with scientific proof of their biological activities. The need for merging of traditional herbal medicine knowledge and cutting-edge scientific techniques is essential to produce novel drugs for the benefit of patients. Investigation of mechanisms of actions and pathways, stimulated by herbal extracts, is critical as this would support the scientific validation of such products prior to their market launch. Therefore, this chapter aims to elaborate such research published in the recent decade, in which herbal preparations, extracts and plant-derived bioactive compounds were utilized to produce scientific proof of anti-disease activity, proliferation stimulant activity and differentiation stimulation or suppression of stem cells and their related plausible mechanisms of action. Also, the chapter would identify research gaps related to effects of herbal extracts on stem cells for use in clinical therapy. This chapter harps on the potential of commercializing herbal-based stem cell therapy, which will also be affordable to the developing world.


2. Effects of herbal extracts on human stem cells

2.1. Stimulatory effects of herbal extracts on human stem cells

Our literature search for the use of herbal preparations to stimulate stem cell proliferation and differentiation in clinical trials resulted in no publications or records, explaining that this area of research is at its infancy harping on the vital necessity of this line of research. However, many studies have been reported on the use of animal models with end results of in vitro studies, cross-linking the above-mentioned research areas, suggesting that the impending phases of research would hopefully culminate in clinical trials, leading to natural products being marketed as commercial stem cell-stimulating agents.

There are several reviews published summarizing the effects of different herbal extracts and their isolated bioactive compounds on human and other mammalian stem cells isolated from different sources. Our review published in 2016 elaborates on osteogenic, anti-adipogenic, neurogenic, endothelial/vascular genesis, angiogenesis and proliferative effects of herbal extracts on human mesenchymal stem cells mostly confirmed by RNA expression studies [8]. Dried root of Korean herb Dipsacus asper had been used in Korean traditional medicine for the treatment of bone fracture and the crude extract, and an isolated compound from the herb hedraganin-3-O-(2-O-acetyl)-α-L-arabinopyranoside demonstrated the osteogenic differentiation ability on bone marrow-derived hMSCs via the upregulation of bone-specific proteins and alkaline phosphatase activity [19]. Aloe emodin, present in Aloe latex, showed anti-adipogenic activity on hMSCs by reducing expression levels of mRNAs (resistin, adiponectin, aP(2), lipoprotein lipase, PPARγ and tumour necrosis factor-α) involved in adipogenic pathways [20]. Treatment of adipose-derived hMSCs with dried root extract of Angelica sinensis, an herb used in traditional Chinese medicine, resulted in significantly higher differentiation of neural-like cells than a commonly used neural inducer, butylated hydroxyanisole [21]. The neuroprotective ability of the same extract was proven by decreased induced neurotoxicity in cultured cortical neurons, increasing the extract’s value as a potential candidate in treating neurodegenerative disorders [22]. A patent was obtained for endothelial differentiation of hMSCs treated with olive leaf extract with overexpression of gene vascular endothelial growth factor, PCAM, platelet-derived growth factor receptor and vascular endothelial growth factor receptor (VEGFR)-1 [23]. An updated list of herbals and mechanism of actions on MSCs, as well as a list of phytochemicals (resveratrol, genistein, naringin, icariin) isolated from plant extracts, were presented in a similar review published in 2017 [24]. As elaborated here, all four isolated compounds had proven their ability to differentiate MSCs into osteoblasts and osteocytes, possibly through the Wnt signalling pathway, upregulating gene expression of RUNX2 and Sirt-1 genes [25, 26, 27]. Combined therapy of adipose-derived hMSCs with icariin showed significantly improved survival rates of hMSCs as well as increased expression of endothelial markers and smooth muscle markers in rat models with diabetes mellitus-induced erectile dysfunction (DMED) inhibiting oxidative stress via the regulation of PI3K/Akt-STAT3 signal pathway [28]. A previous review published in 2014 demonstrated the well-established link between herbal preparations used in Ayurveda for a wide array of disorders with their proliferation and differentiation effects which were utilized in similar capacities on stem cell differentiation and proliferation, providing scientific proof of thousands of years old Ayurvedic predictions and practices [29]. Rasayana, the branch of Ayurveda which explains rejuvenation and immunomodulation, has listed the use of approximately 200 herbs [28] which could be investigated for their regeneration capacities on stem cells. Medhya Rasayana, an intellectual/retention rejuvenation therapy method in Ayurveda that consists of four herbal plants, could be used individually or in combination [30]. Studies on stem cells treated with Medhya Rasayana extracts have shown the expression of nestin on stem cells, an early neural stem cell marker [29], confirming the ability of Medhya herbs to treat disorders related to the neural system by increasing the differentiation ability of stem cells.

A growing concern of ameliorating radiation-induced normal tissue injury is arising as it affects the well-being of cancer patients. Stem cell therapy is used to replace these cells and tissues, and many examples are elaborated in the review of Benderitter et al. [31]. Authors have reviewed a number of studies related to ameliorating radiation-induced myelopathy by transplanting neural stem cells to the spinal code [32], potential applications of transplanting salivary gland stem cells in patients with radiation-induced xerostomia [31], potential benefits of transplanting stem cells and biomaterial in animal models with osteoradionecrosis [33] and transplanting autologous fat drafts including adipose-derived stem cells to treat radiation-induced late skin complications [34]. As herbal extracts had proven their differentiation aiding capabilities in in vitro studies, they could act as stimulants to produce increased numbers of stem cells required for patient transplantations. The following figure illustrates the different sources of human mesenchymal stem cells (hMSCs) and their differentiation capabilities with advantages and disadvantages of herbal stimulants and synthetic stimulants (Figure 1) [8].

Figure 1.

A glimpse of hMSC sources and their differentiation capabilities stimulated with herbal extracts or synthetic stimulants (Courtesy: Udalamaththa et al. [8]).

Although most of the reported research was on hMSCs, haematopoietic stem cells (HSCs) are also being investigated for their properties of proliferation and differentiation when treated with herbal extracts and their isolated compounds. Proliferation, differentiation and in vitro expansion of healthy hHSCs are important as many haematological malignancies disrupt the healthy hHSC populations. A review that summarizes a wide range of research publications on the use of Chinese herbal medicine (CHM) to promote recovery after HSC transplantation had elaborated the positive results of herbal extracts from plants such as Sheng Di Huang (Rehmannia glutinosa), Bai Zhu (Atractylodes macrocephala), Ren Shen (Panax), Dang Shen (Codonopsis pilosula), Mai Men Dong (Ophiopogon japonicus), Dang Gui (Angelica sinensis), Tai Zi Shen (Pseudostellaria heterophylla), Huang Qi (Astragalus membranaceus) and Ejiao (Equus asinus) [35]. A study on autologous and allogenic HSC transplanted in patients with chronic granulocytic leukaemia, acute non-lymphocytic leukaemia and lymphoma were treated with CHM concluded that treating with CHM reduces complications of transplantations and promotes recovery of haematopoietic functions [36]. More research on various other HSC transplantations against haematological malignancies such as severe aplastic anaemia patients [37], patients with myelodysplastic syndrome [38] and acute paediatric leukaemia [39] were cited herein [35], which had given positive results on patient survival rates, reduction of complications and increasing functional properties of haematopoietic cells. However, most of these studies were based on a low number of samples; hence, the need to perform such studies in large populations arises in order to validate and standardize the CHM procedures. In vitro studies and animal model studies had also been reported on HSC proliferation and differentiation to gather more scientific evidence to support small local clinical trials performed in isolation in individual countries. EMSA eritin, a polyherbal formulation had increased proliferation of HSC in irradiated BALB/c mice in vivo and triggered differentiation into the lymphopoiesis lineages [40]. Inducing of proliferation and attenuating of apoptosis were observed when an immune-mediated aplastic anaemia mouse model was treated with a modified Chinese herbal formula prepared with Radix astragali, Radix Angelicae sinensis and Coptis chinensis Franch [41].

Although stem cell therapy had boosted disease therapy into the next level of modern therapeutic medicine, a major limitation is their poor survival after transplantation into the host, which could be resolved by supplementing the microenvironment with vitamins and other antioxidants [29] and other preconditioning strategies such as exposure to hypoxic conditions, oxidative stress and heat shock treatments [42]. Scientists are studying natural plant extracts and their isolated compounds as alternatives to synthetic growth factors and other stimulants to precondition the microenvironment for the survival of stem cells in vivo, as there are many reports on the presence of a wide array of beneficial phytochemicals in plants. Pretreatment of adipose-derived hMSCs with C. setidens herbal extract had resulted in increased survival of hMSCs by inhibiting ROS-induced apoptosis, suggesting the suitability of the extract to prevent ROS-induced oxidative stress by regulating the oxidative stress-associated signalling pathway and suppressing the apoptosis-associated signal pathway [43]. Extract of Origanum vulgare had protected murine mesenchymal stem cells from oxidative stress when preconditioned with high doses via significantly decreasing caspase-3 activity [44]. Tinospora cordifolia and Withania somnifera, two widely used herbs used in Ayurveda for rejuvenating and anti-ageing treatment, had shown increase in proliferation and inhibition of senescence in WJ-MSCs in vitro [45], suggesting that pretreatment with these herbals would aid in in vivo transplantation procedures.

2.2. Inhibitory effects of herbal extracts on cancer stem cells

Cancer stem cells (CSCs), the cells which are capable of self-renewal and produce the heterogeneous lineage of cancer cells [46], has become the most complicated issue in cancer therapy. A number of studies were reported which resulted in the reduction of cancer cells with the treatment of isolated phytochemicals such as epigallocatechin-3-gallate (EGCG), curcumin, resveratrol, lycopene, pomegranate extracts, luteolin, genistein, piperin, β-carotene and sulforaphane [45]. Specifically, sulforaphane, a phytochemical isolated from broccoli, had apoptosis-inducing effects on pancreatic CSCs [47] and could target breast CSCs effectively [48].

However, in this scenario, scientists are changing their approach in the search for natural products by trying to select herbal extracts and preparations known to be effective against cancers in traditional medicine. This approach would be advantageous for both ends of traditional medicine and modern therapeutics, as traditional medicine will have a chance of proving the remedies in a scientific platform and also the modern therapeutics would have the benefit of using time tested anticancer remedies rather than screening thousands of plant extracts for this purpose without any clues. A review on targeting CSCs using TCM remedies and their active compounds had elaborated several approaches of herbal remedies acting on CSCs. Reversion of drug resistance of CSCs, inducing cell death and inhibiting cell proliferation, inhibiting metastasis and targeting CSCs-related miRNAs are the explained methods of TCM remedies targeting CSCs [49]. Berberine liposomes, isolated from rhizome of Coptis chinensis, showed anticancer effects on human breast CSCs transplanted in nude mice by penetrating the cell membrane, accumulating in mitochondria of CSCs and resulting in reversion of drug resistance and apoptotic pathway inducing cell death and inhibiting cell proliferation [50]. Curcumin and epigallocatechin gallate (EGCG) had synergistically targeted breast CSCs by downregulating stemness genes and inducing differentiation of these into non-stem cells [51]. Prostate cancer metastasis had been reduced by a combination of quercetin, extracted from Dysosma veitchii and EGCG by reducing activity of LEF-1/TCF responsive receptor [52]. Honokiol, a lignan isolated from Magnolia officinalis, had inhibited renal cancer metastasis by regulating miR-141/ZEB2 signalling [53]. Triphala, a widely used formulation in Ayurveda, had shown anticancer properties on human colon cancer stem cells by p53-independent proliferation inhibition and apoptosis inducing [54]. Also, a Sri Lankan group of scientists had investigated on anticancer properties of gedunin, a major compound found in Azadirachta indica, which confirmed its apoptotic-inducing properties against human embryonal carcinoma cells—a cancer stem cell model [55].

2.3. Commercial herbal products with claims of stem cell rejuvenation

Many herbal products are commercialized with claims to be rejuvenating adult stem cells which are considered as stem cell supplements. The first stem cell enhancer was developed and patented by Dr. Sahelian of Stemtech HealthSciences, Inc. in 2005 [56] which included extracts of freshwater microalgae and marine macroalgae [57]. Stem Cell 100® is a patent pending product prepared from bioactive compounds of herbal plants Astragalus membranaceus, Vaccinium, Pine bark, Camellia sinensis, Pterocarpus marsupium, Polygonum multiflorum, Schisandra, Fo-Ti root and Drynaria rhizome mainly derived from TCM [58]. ProxyStem is another patent pending nutraceutical stem cell supplement with claims to be working on pro-inflammatory pathways, endothelial cell health, oxidative stress protection, mitochondrial function and artery support [59].

Another product, NutraStem Active, was awarded a patent for claims of its ability to promote adult stem cells with its four ingredients—blueberry extract, green tea extract, L-carnosine and vitamin D3 [60]. Stem-Kine, a clinically proven stem cell supplement, includes ellagic acid which protects stem cells from free radicals [61]; it is a polyphenol compound extracted from mainly a plant of the berry family [62].


3. Pros and cons of using herbal remedies to stimulate stem cells

Traditional herbal treatment provides a straightforward method to identify the link between plant/herbal remedies and their use in curing different diseases. Modern scientists now use the same strategy to identify herbal plants and their isolated compounds which could be used as stem cell stimulants for much needed stem cell therapeutic procedures. Studies were initiated in this line of research in developed countries as well as in the developing countries acquiring their own traditional herbal treatment knowledge. China seems to be much ahead in this hybrid system of research using Chinese traditional herbs/isolated compounds and cutting-edge screening technologies. Although there is a plethora of internationally published research by research groups from China, many clinical trials and small population studies seem to be concealed from the rest of the world as these reports are published in local journals in their native language [35]. China is not alone in this exercise. Other countries such as Iran and Pakistan too with rich traditional medicine cultures and also into stem cell research are posing the same issue, as the data they produce are not communicated to the international scientific community. This is an unfortunate situation which could be rectified to be more productive through collaborative research with the rest of the world.

In certain instances, developing countries offer their knowledge of traditional herbal medicine together with their rich local plant diversity to collaborate with developed countries to obtain cutting-edge technologies to achieve high potential results in their research. However, the strict local regulations and policies on shipping indigenous plant material or their compounds in developing countries, in order to protect their own plant species, had restricted this productive collaborative research frame work, as this process is lengthy which would lead to late initiation of laboratory investigations.

Another concern is that of the withdrawal of traditional herbal practitioners from providing information on their herbal remedies to the scientists for investigations; it is the latter who have the ability to scientifically prove that these remedies are actually therapeutically potent. Traditional practices are said to be handed down from generation to generation within families, and most of these practitioners treat patients pro bono, as a social service. Since these practitioners claim to have satisfactory results from providing such treatment, they have no reason to give away their herbal remedies, which had been a family secret for over hundreds of years. However, the modern graduates of traditional medicine are more into scientifically validating their treatment methods, as it is beneficial for their practice to have scientifically proven results to compete with Western medicine practitioners. Most traditional medicine practitioners vary the constituents of herbal preparations and the ratios used in their prescriptions even for the same disease depending on the patient’s individual constitution, indicative of the practise of ‘personalized/precision medicine’. ‘Ayugenomics’ irrevocably established that a genetic basis did indeed exist to the said individual constitutions [63]; differential DNA methylation signatures in the three distinct ‘prakriti’ phenotypes (based on distinctly descriptive physiological, psychological and anatomical features of different individuals) demonstrated the epigenetic basis of traditional human classification in Ayurveda with relevance to personalized medicine [64]. Yet, allopathic medicine strongly believes in standard preparations where only the dose is varied among individual patients. Hence, there arises the question whether modern standardized herbal preparations would be universally effective on every patient.

Nevertheless, herbal remedies that were scientifically investigated for their properties with elucidated mechanisms and pathways of action too may face further obstacles prior to their market launch. As mentioned in the review of Udalamaththa et al., a large-scale manufacturing process may reduce the crude properties of herbal remedies, solvents used to prepare extracts may produce adverse effects when used in therapy, complexity and variability of bioactive compounds may make clinical applications challenging [8]. As standardization of herbal products is a must prior to the market launch, similar and stringent regulations will be applied to herbal stem cell stimulants which are to be used in therapy.

Yet, despite all issues involved, pharmaceutical companies are competing for patents and commercializing herbal stimulants, supplements and many more drugs which could be used in stem cell therapy.


4. Conclusion

Herbal medicine has at all times been a trusted treatment method from ancient eras. The paucity of the use of herbal medicine or related treatment methods in allopathic medicine practices or other types of therapy using cutting-edge technology may pose the ‘missing part of the puzzle’ which scientists and clinicians have strived to solve. However, in recent years, both traditional medicine and novel technologies in synergy have resulted in beneficial outcomes advantageous to the patients. Examples presented in this chapter provide a glimpse of recent studies where herbal medicine and stem cells have been amalgamated in search of treatment against ‘incurable diseases’. Although the use of medicinal plants in stem cell research is in its infancy, with small population studies within local communities, with low numbers of related patents and many complexities in application in a clinical setting, the attraction of this area of research has never ebbed due to the promising results emerging from basic scientific research. Preliminary trials leading to the initiation of in-depth studies may well result in inexpensive, available, nontoxic drugs, stimulants and supplements useful in stem cell therapy.



The authors gratefully acknowledge funding by the National Science Foundation, Sri Lanka (RG/2015/HS/01).


  1. 1. World Health Organization, [Internet]. 2017. Available from: [Accessed: August 25, 2017]
  2. 2. Pan SY, Litscher G, Gao SH, Zhou SF, Yu ZL, Chen HQ, Zhang SF, Tang MK, Sun JN, Ko KM. Historical perspective of traditional indigenous medical practices: The current renaissance and conservation of herbal resources. Evidence-Based Complementary and Alternative Medicine. Apr 27, 2014;2014:525340
  3. 3. Edwards E, Da-Costa-Rocha I, Lawrence MJ, Cable C, Heinrich M. Use and efficacy of herbal medicines: Part 1—Historical and traditional use. The Pharmaceutical Journal. Aug 11, 2012;288:685-686
  4. 4. Sharma CP. Ravana: A great scholar and scientist. Journal of Gampaha Wickramarachchi Ayurveda Institute. 2000;2(1):19-20
  5. 5. Petrovska BB. Historical review of medicinal plants’ usage. Pharmacognosy Reviews. Jan 2012;6(11):1
  6. 6. Andrade-Cetto A, Heinrich M. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. Journal of Ethnopharmacology. Jul 14, 2005;99(3):325-348
  7. 7. Parikh NH, Parikh PK, Kothari C. Indigenous plant medicines for health care: Treatment of Diabetes mellitus and hyperlipidemia. Chinese Journal of Natural Medicines. May 1, 2014;12(5):335-344
  8. 8. Udalamaththa VL, Jayasinghe CD, Udagama PV. Potential role of herbal remedies in stem cell therapy: Proliferation and differentiation of human mesenchymal stromal cells. Stem Cell Research & Therapy. Aug 11, 2016;7(1):110
  9. 9. Ali TF, Hasan T. Phlorotannin-incorporated mesenchymal stem cells and their promising role in osteogenesis imperfecta. Journal of Medical Hypotheses and Ideas. Jul 31, 2012;6(2):85-89
  10. 10. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. Journal of Natural Products. Mar 23, 2007;70(3):461-477
  11. 11. Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R. Overview of major classes of plant-derived anticancer drugs. International Journal of Biomedical Science: IJBS. Mar 2009;5(1):1
  12. 12. Gothai S, Ganesan P, Park SY, Fakurazi S, Choi DK, Arulselvan P. Natural phyto-bioactive compounds for the treatment of type 2 diabetes: Inflammation as a target. Nutrients. Aug 4, 2016;8(8):461
  13. 13. Stallings AF, Lupo MP. Practical uses of botanicals in skin care. The Journal of Clinical and Aesthetic Dermatology. Jan 2009;2(1):36
  14. 14. Mohamed GA, Ibrahim SR, Elkhayat ES, El Dine RS. Natural anti-obesity agents. Bulletin of Faculty of Pharmacy, Cairo University. Dec 31, 2014;52(2):269-284
  15. 15. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling. May 14, 2011;9(1):12
  16. 16. Wilson KD, Wu JC. Induced pluripotent stem cells. Journal of American Medical Association. Apr 28, 2015;313(16):1613-1614
  17. 17. Kim C. iPSC technology-powerful hand for disease modeling and therapeutic screen. BMB Reports. May 2015;48(5):256
  18. 18. Pires AO, Mendes-Pinheiro B, Teixeira FG, Anjo SI, Ribeiro-Samy S, Gomes ED, Serra SC, Silva NA, Manadas B, Sousa N, Salgado AJ. Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: A proteomic analysis. Stem Cells and Development. May 25, 2016;25(14):1073-1083
  19. 19. Kim BS, Kim YC, Zadeh H, Park YJ, Pi SH, Shin HS, You HK. Effects of the dichloromethane fraction of Dipsaci Radix on the osteoblastic differentiation of human alveolar bone marrow-derived mesenchymal stem cells. Bioscience, Biotechnology, and Biochemistry. Jan 23, 2011;75(1):13-19
  20. 20. Subash-Babu P, Alshatwi AA. Aloe-emodin inhibits adipocyte differentiation and maturation during in vitro human mesenchymal stem cell adipogenesis. Journal of Biochemical and Molecular Toxicology. Aug 1, 2012;26(8):291-300
  21. 21. Wang Q, Zhou L, Guo Y, Liu G, Cheng J, Yu H. Differentiation of human adipose-derived stem cells into neuron-like cells by Radix Angelicae Sinensis. Neural Regeneration Research. Dec 15, 2013;8(35):3353
  22. 22. Huang SH, Lin CM, Chiang BH. Protective effects of Angelica Sinensis extract on amyloid beta-peptide-induced neurotoxicity. Phytomedicine. 2008;15(9):710-721
  23. 23. Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis US 20120141435 A1. In: Patents. 2012. Available from: [Accessed: November 18, 2015]
  24. 24. Kornicka K, Kocherova I, Marycz K. The effects of chosen plant extracts and compounds on mesenchymal stem cells—A bridge between molecular nutrition and regenerative medicine-concise review. Phytotherapy Research. Jan 1, 2017;31(7):947-958
  25. 25. Tseng PC, Hou SM, Chen RJ, Peng HW, Hsieh CF, Kuo ML, Yen ML. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. Journal of Bone and Mineral Research. Oct 1, 2011;26(10):2552-2563
  26. 26. Zhou H, Shang L, Li X, Zhang X, Gao G, Guo C, Chen B, Liu Q, Gong Y, Shao C. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Experimental Cell Research. Oct 15, 2009;315(17):2953-2962
  27. 27. Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chemical Biology & Drug Design. Dec 1, 2009;74(6):619-624
  28. 28. Wang X, Liu C, Xu Y, Chen P, Shen Y, Xu Y, Zhao Y, Chen W, Zhang X, Ouyang Y, Wang Y. Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction. PLoS One. Mar 28, 2017;12(3):e0174145
  29. 29. Joshi KS, Bhonde R. Insights from Ayurveda for translational stem cell research. Journal of Ayurveda and Integrative Medicine. Jan 2014;5(1):4
  30. 30. Gomathi M, Balachandar V. Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology. Stem Cell Investigation. 2017;4:20
  31. 31. Benderitter M, Caviggioli F, Chapel A, Coppes RP, Guha C, Klinger M, Malard O, Stewart F, Tamarat R, Van Luijk P, Limoli CL. Stem cell therapies for the treatment of radiation-induced normal tissue side effects. Antioxidants & Redox Signaling. Jul 10, 2014;21(2):338-355
  32. 32. Rezvani M, Birds DA, Hodges H, Hopewell JW, Milledew K, Wilkinson JH. Modification of radiation myelopathy by the transplantation of neural stem cells in the rat. Radiation Research. Oct 2001;156(4):408-412
  33. 33. Espitalier F, Vinatier C, Lerouxel E, Guicheux J, Pilet P, Moreau F, Daculsi G, Weiss P, Malard OA. Comparison between bone reconstruction following the use of mesenchymal stem cells and total bone marrow in association with calcium phosphate scaffold in irradiated bone. Biomaterials. Feb 28, 2009;30(5):763-769
  34. 34. Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S. Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury. Stem Cells International. Dec 1, 2010;2010:532704-532712
  35. 35. Fleischer T, Chang TT, Yen HR. Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need. Journal of Integrative Medicine. Sep 30, 2016;14(5):322-335
  36. 36. Yu RX, Zhou YH, Zhu NX. Twelve cases of malignant hematopathy treated by combined therapy of hematopoietic stem cell transplantation and Chinese herbal medicine. ZhongguoZhong Xi Yi Jie He ZaZhi. 2001;21(2):90-93
  37. 37. Ye BD, Zhang X, Shao KD, Chen D, Zhang Y, DJ W, QH Y, Shen JP, Shen YP, Zhou YH. Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients. Chinese Journal of Integrative Medicine. Dec 1, 2014;20(12):903-909
  38. 38. Zhang Y, Ye BD, Qian LL, Gao YT, Wen XW, Shen JP, Zhou YH. Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: A clinical study. ZhongguoZhong Xi Yi Jie He ZaZhi. 2015;35(1):53-56. Chinese with abstract in English
  39. 39. Shi L, Cheng Z, Chen SM, Qin XL, Wang H. Autologous peripheral blood stem cell transplantation combined with traditional Chinese medicine therapy on acute leukemia inchildren. Shi Yong ErKe Lin Chuang ZaZhi. 2010;25(3):209-210. Chinese with abstract in English
  40. 40. Ibrahim M, Widjajanto E, Widodo MA, Sumitro SB. Adequate stimulation of hematopoietic stem cell proliferation by a polyherbal formulation (EMSA eritin) leading to lymphocyte differentiation in BALB/c mice after radiation. Biomarkers and Genomic Medicine. Sep 30, 2015;7(3):110-115
  41. 41. Zhou J, Li X, Deng P, Wei Y, Liu J, Chen M, Xu Y, Zhang D, Zhu L, Lou L, Dong B. Chinese herbal formula, modified Danggui Buxue tang, attenuates apoptosis of hematopoietic stem cells in immune-mediated aplastic Anemia mouse model. Journal of Immunology Research. 2017;2017:9786972
  42. 42. Haider HK, Ashraf M. Preconditioning and stem cell survival. Journal of Cardiovascular Translational Research. Apr 1, 2010;3(2):89-102
  43. 43. Lee JH, Jung HK, Han YS, Yoon YM, Yun CW, Sun HY, Cho HW, Lee SH. Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells. Molecular Medicine Reports. Oct 1, 2016;14(4):3777-3784
  44. 44. Mohammadzadeh-Vardin M, Sagha M. Using herbal preconditioning, extract of Origanum vulgare protects the mesenchymal stem cells from the oxidative stress. In: Abstracts of the 12th Royan International Congress on Stem Cell Biology & Technology; Iran. Cell Journal. 2016;18(Suppl 1):50
  45. 45. Sanap A, Chandravanshi B, Shah T, Tillu G, Dhanushkodi A, Bhonde R, Joshi K. Herbal pre-conditioning induces proliferation and delays senescence in Wharton’s jelly mesenchymal stem cells. Biomedicine & Pharmacotherapy. Sep 1, 2017;93:772-778
  46. 46. Scarpa ES, Ninfali P. Phytochemicals as innovative therapeutic tools against cancer stem cells. International Journal of Molecular Sciences. Jul 10, 2015;16(7):15727-15742
  47. 47. Kallifatidis G, Rausch V, Baumann B, Apel A, Beckermann BM, Groth A, Mattern J, Li Z, Kolb A, Moldenhauer G, Altevogt P. Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling. Gut. Jul 1, 2009;58(7):949-963
  48. 48. Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, Sun D. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clinical Cancer Research. May 1, 2010;16(9):2580-2590
  49. 49. Hong M, Tan HY, Li S, Cheung F, Wang N, Nagamatsu T, Feng Y. Cancer stem cells: The potential targets of Chinese medicines and their active compounds. International Journal of Molecular Sciences. Jun 7, 2016;17(6):893
  50. 50. Ma X, Zhou J, Zhang CX, Li XY, Li N, RJ J, Shi JF, Sun MG, Zhao WY, LM M, Yan Y. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. Jun 30, 2013;34(18):4452-4465
  51. 51. Chung SS, Vadgama JV. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3–NFκB signaling. Anticancer Research. Jan 1, 2015;35(1):39-46
  52. 52. Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK. The dietary bioflavonoid quercetin synergizes with epigallocatechingallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. Journal of Molecular Signaling. Aug 18, 2010;5(1):14
  53. 53. Li W, Wang Q, Su Q, Ma D, An C, Ma L, Liang H. Honokiol suppresses renal cancer cells’ metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling. Molecules and Cells. May 2014;37(5):383
  54. 54. Vadde R, Radhakrishnan S, Reddivari L, Vanamala JK. Triphala extract suppresses proliferation and induces apoptosis in human colon cancer stem cells via suppressing c-Myc/Cyclin D1 and elevation of Bax/Bcl-2 ratio. BioMed Research International. Jun 17, 2015;2015:649263
  55. 55. Tharmarajah L, Samarakoon SR, Ediriweera MK, Piyathilaka P, Tennekoon KH, Senathilake KS, Rajagopalan U, Galhena PB, Thabrew I. In vitro anticancer effect of Gedunin on human Teratocarcinomal (NTERA-2) cancer stem-like cells. BioMed Research International. Jun 7, 2017;2017:2413197
  56. 56. Ray Sahelian. Stem Cell Enhancers and Natural Medicine Information [Internet]. 2016. Available from: [Accessed: September 3, 2017]
  57. 57. Cerule [Internet]. 2016. Available from: [Accessed: September 3, 2017]
  58. 58. Stem Cell 100 [Internet]. 2011. Available from: [Accessed: September 2, 2017]
  59. 59. RevGenetics [Internet]. 2017. Available from: [Accessed: September 2, 2017]
  60. 60. Natura Therapeutics, Inc. [Internet]. 2007-2014. Available from: [Accessed: September 3, 2017]
  61. 61. Stem-Kine [Internet]. 2017. Available from: [Accessed: September 3, 2017]
  62. 62. PubChem, Open Chemistry Data Base [Internet]. 2004. Available from: [Accessed: September 3, 2017]
  63. 63. Patwardhan B, Bodeker G. Ayurvedic genomics: Establishing a genetic basis for mind-body typologies. Journal of Alternative Complementary Medicine. Jun 2008;14(5):571
  64. 64. Rotti H, Mallya S, Kabekkodu SP, Chakrabarty S, Bhale S, Bharadwaj R, Bhat BK, Dedge AP, Dhumal VR, Gangadharan GG, Gopinath PM, Govindaraj P, Joshi KS, Kondaiah P, Nair S, Nair SN, Nayak J, Prasanna BV, Shintre P, Sule M, Thangaraj K, Patwardhan B, Valiathan MV, Satyamoorthy KDNA. Methylation analysis of phenotype specific stratified Indian population. Journal of Translational Medicine. May 8, 2015;13:151

Written By

Preethi Vidya Udagama and Vindya Udalamaththa

Submitted: 21 May 2017 Reviewed: 24 November 2017 Published: 05 November 2018